Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...

Weight loss tops many folks' list of New Year's resolutions, and lots of people are turning to cutting-edge weight-loss drugs ...

Blood sugar and insulin levels also depend on the vagus nerve. As blood sugar levels rise, the vagus nerve stimulates the ...

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

Objective—Glucagon-like peptide 1 (GLP-1) exerts beneficial antidiabetic actions via effects on pancreatic β- and α-cells. Previous studies have focused on the improvements in β-cell function ...

The only exceptions are Survodutide, Retatrutide, and Efinopegdutide, which all have less Glucagon content than Pemvidutide. By combining direct and indirect mechanisms of action (MOA) in one drug ...

Clinical trials in 2024 highlight the expanded benefits of glucagon-like peptide 1-based ... with obesity and metabolic dysfunction. The mechanisms involved in these health benefits appear to ...

These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...